Upstream Bio, Inc. Common Stock UPB
$2.76
-18.10%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (4 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $29.67
- Implied Upside
- +974.9%
- Price Target Range
- $9.00 – $50.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-02 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2026-08-14 | JP MorganTessa Romero |
Maintains | Neutral | $8 → $9 |
| 2026-08-12 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $43 → $25 |
| 2026-06-12 | JP MorganTessa Romero |
Downgrades | Overweight → Neutral | $35 → $8 |
| 2026-06-03 | HC Wainwright & Co.Matthew Caufield |
Initiates coverage on | Buy | $36 |
| 2026-05-14 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $51 → $50 |
| 2026-03-27 | Evercore ISI GroupCory Kasimov |
Downgrades | Outperform → In-line | $40 → $15 |
| 2025-12-18 | MizuhoJoseph Catanzaro |
Initiates coverage on | Outperform | $51 |
| 2025-12-02 | LifeSci Capital |
Initiates coverage on | Outperform | $43 |
| 2025-11-18 | Evercore ISI GroupCory Kasimov |
Initiates coverage on | Outperform | $40 |
| 2025-10-14 | Truist SecuritiesDanielle Brill |
Initiates coverage on | Buy | $47 |
| 2024-11-05 | JP MorganTessa Romero |
Initiates coverage on | Overweight | $38 |
| 2024-11-05 | William BlairMatt Phipps |
Initiates coverage on | Outperform | — |
| 2024-11-05 | TD CowenYaron Werber |
Initiates coverage on | Buy | — |
| 2024-11-05 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $75 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.76
- Market Cap
- $151.17 million
- 52-Week Range
- $2.74 – $33.68
- Average Volume
- 875K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.